BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21380782)

  • 1. The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.
    Zhang MS; Hu AH; Qiu H; Xiong HH; Chen Y
    Med Oncol; 2012 Jun; 29(2):928-32. PubMed ID: 21380782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
    Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
    Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1.
    Yan Y; Shen Z; Ye Y; Jiang K; Zhang H; Shen C; Mustonen H; Puolakkainen P; Wang S
    Med Oncol; 2014 Feb; 31(2):816. PubMed ID: 24366689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.
    Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M
    Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and significance of the Wip1 proto-oncogene in colorectal cancer.
    Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ
    Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients.
    Lee HY; Ahn JB; Rha SY; Chung HC; Park KH; Kim TS; Kim NK; Shin SJ
    World J Surg Oncol; 2014 Jul; 12():232. PubMed ID: 25060774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma.
    Evertsson S; Bartik Z; Zhang H; Jansson A; Sun XF
    Int J Oncol; 1999 Jul; 15(1):53-8. PubMed ID: 10375593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer.
    Qu L; Liang L; Su J; Yang Z
    Eur J Cancer Prev; 2013 Nov; 22(6):512-22. PubMed ID: 23765094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.
    Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH
    Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Wang X; Wang J; Ma H; Zhang J; Zhou X
    Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
    Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
    Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular biologic characteristics of early-onset versus late-onset colorectal carcinoma in Filipinos.
    Uy GB; Kaw LL; Punzalan CK; Querol RI; Koustova EV; Bowyer MW; Hobbs CM; Sobin LH; Wherry DC
    World J Surg; 2004 Feb; 28(2):117-23. PubMed ID: 14708047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients.
    Harder J; Engelstaedter V; Usadel H; Lassmann S; Werner M; Baier P; Otto F; Varbanova M; Schaeffner E; Olschewski M; Blum HE; Opitz OG
    Br J Cancer; 2009 Jan; 100(2):360-5. PubMed ID: 19142184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.